2004 PAREXEL News
| December 16, 2004 | PAREXEL ANNOUNCES DATE OF SECOND QUARTER EARNINGS RELEASE AND CONFERENCE CALL |
| December 13, 2004 | BARNETT RELEASES NEW DRUG DEVELOPMENT: A REGULATORY OVERVIEW |
| November 19, 2004 | PAREXEL CONSULTING TO VALIDATE FIRST CGMP BIOPHARMACEUTICAL CONTRACT MANUFACTURING FACILITY IN SOUTH KOREA |
| October 20, 2004 | PAREXEL REPORTS FIRST QUARTER FISCAL 2005 FINANCIAL RESULTS |
| October 7, 2004 | PAREXEL INTERNATIONAL ACQUIRES INTEGRATED MARKETING CONCEPTS |
| September 29, 2004 | PAREXEL ANNOUNCES DATE OF FIRST QUARTER EARNINGS RELEASE AND CONFERENCE CALL |
| September 20, 2004 | PAREXEL INTERNATIONAL INTRODUCES PAREXEL CONSULTING |
| September 15, 2004 | PAREXEL INTERNATIONAL ANNOUNCES VICE PRESIDENT AND UNIT DIRECTOR OF CLINICAL PHARMACOLOGY |
| September 14, 2004 | PAREXEL INTERNATIONAL APPOINTS KURT BRYKMAN AS PRESIDENT, PAREXEL CONSULTING |
| September 13, 2004 | BARNETT RELEASES STATE CLINICAL TRIAL REQUIREMENTS REFERENCE GUIDE |
ShareAbout PAREXEL
PAREXEL is a leading global bio/pharmaceutical services organization that helps clients expedite time-to-market through our development and launch services. These include a broad range of clinical development capabilities, integrated advanced technologies, regulatory affairs consulting, and commercialization services.
Related Contacts
Jennifer Baird
Senior Director of Public Relations
PAREXEL International
Tel: +781-434-4409
jennifer.baird@PAREXEL.com
Gene Carozza
PAN Communications
Tel: + 978-474-1900
PAREXEL@pancomm.com